David Michael Steinhaus MD

Dr. David M. Steinhaus, M. D., joined Medtronic, Inc., in 2005 after serving as Executive Medical Director, Mid America Heart Institute, St. Luke’s Health System, in Kansas City, MO. In his current position in Cardiac Rhythm Disease Management (CRDM) as Vice President and General Manager, Heart Failure, and Medical Director, Steinhaus is responsible for leading the heart failure business including cardiac resynchronization therapy. His responsibilities also include bringing the physician voice to CRDM and serving as the liaison to government agencies, professional societies, and medical groups. In addition, his leadership responsibilities include strategic business investments.

Dr. Steinhaus has been closely associated with research and academia, performing extensive clinical study in implantable cardiac devices and leads. He has multiple publications in peer-reviewed journals and has testified for the Senate Committee on the Food and Drug Administration. Steinhaus served as Chair of the Department of Cardiology, and Director of the Electrophysiology Department at Mid America Heart Institute and St. Luke’s Hospital, Director of the Electrophysiology Fellowship Program at the University of Missouri at Kansas City School of Medicine and Mid America Heart Institute, Saint Luke’s Hospital, and has instructed students in medicine since 1982. Dr. Steinhaus is the immediate past President of the International Board of Heart Rhythm Examiners (formerly NASPExAM). He also led the Kansas City Heart Safe Community Project to place automated external defibrillators in public places and to increase public awareness of sudden cardiac arrest.